Digita Selects Netmore Platform-as-a-Service to Scale LoRaWAN®-based IoT Network Capabilities in Finland
2.12.2024 08:00:00 CET | Business Wire | Press release
Digita and Netmore to Jointly Develop Large-Scale Projects in Utility, Building, Construction, and Logistics Verticals
Netmore Group, a leading global LoRaWAN network operator, today announced that Digita, a Finnish technology company specializing in broadcast networks and telecom services, has selected Netmore’s Operator Platform-as-a-Service (PaaS) to expand, optimize, and scale its LoRaWAN network capabilities for the delivery of Internet of Things (IoT) applications in Finland. The leading domestic network operator, Digita offers a complete infrastructure for IoT services including a nationwide public LoRaWAN network and private network build outs based on customer needs.
With an extensive and growing base of digital transformation deployments across the utility, district heating, smart building, and logistics verticals, Digita selected Netmore’s PaaS offering to reduce the number of systems needed to deliver IoT connectivity to its customers. In addition to streamlining its operations, Digita benefits from economies of scale derived from the shared efficiencies of Netmore’s platform which is used to manage core network and connected device services for the largest carrier-grade LoRaWAN networks in the world.
Digita supports its domestic customers with cost-effective future-proof IoT connectivity and through international roaming cooperation can now easily expand into new markets outside of Finland where Netmore and its partners operate LoRaWAN networks. Further, Netmore customers have immediate access to the Digita network to support business opportunities in Finland, providing Digita with new customer revenue streams.
“Designed for massive IoT and for provisioning and managing millions of devices, Netmore PaaS provides the advanced features and future-proof connectivity we need to scale our IoT business,” said VP, IoT Tuomas Kolkka at Digita. “Our companies have a shared vision of what is needed to support digital transformation across industries and an alignment on customer-centric business practices that will drive adoption faster.”
This collaboration significantly expands the IoT capabilities available to businesses in Finland, facilitating seamless integration of digital solutions that promote both economic growth and environmental sustainability.
“The growing demand for reliable and scalable IoT solutions in support of resource conservation and sustainability initiatives is driving the adoption of Netmore PaaS across the globe,” said Andreas Stenhager, Chief Commercial Officer at Netmore Group. “Digita’s strong market presence in Finland will enable new innovations in the delivery of digital services and we are excited to have them join our growing Operator PaaS ecosystem. Together, we are setting a new standard for IoT deployments and digital transformation, not just in Finland, but across the broader European and global markets.”
A trusted expert in network and device migrations, Netmore ensures an interruption-free migration process, keeping IoT operations running smoothly with no downtime. For more information on deploying or migrating to Netmore’s Platform-as-a-Service, contact info@netmoregroup.com.
About Netmore Group
Netmore Group is an IoT network operator, building the leading multinational network to advance sustainable business practices. We offer a reliable network platform and leading connectivity expertise for efficient measuring, monitoring, and optimisation of resource use. With 10 years in the industry, we have a solid track record, operating borderless on the European market and have grown to become a leading global network operator. Netmore group’s main owner is the Nordic infrastructure investor Polar Structure.
About Digita
Digita is a provider of digital infrastructure and services and is Finland’s largest independent owner of telecommunication masts. The company owns and operates Finland’s leading terrestrial network for nationwide TV and radio transmissions, is a pay-TV operator on the terrestrial television network and develops broadcasting services for the future. Digita’s telecommunications services include private networks, indoor coverage solutions, management services for rooftop telecommunications installations, IoT and data center services. The company provides services to media companies, consumers, mobile phone operators, industry, infrastructure enterprises and real estate owners. www.digita.fi
View source version on businesswire.com: https://www.businesswire.com/news/home/20241201696580/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 15:07:00 CEST | Press release
Initial planning calls for Data Sciences Division to focus efforts in cyber secure infrastructure with dedication in fintech and patented Information Data Exchange® (IDE®) Management will harness its API Media acquisition, robust patent portfolio, ADIO® Inaudible Tones, WiSA® and Dolby® partnerships to establish worldwide acoustic industry standards in high-definition wireless transmission, spatial-audio control and interoperability Plan includes API media’s stand-alone and renewed execution of WiSA semiconductor and software modules strategy with an R&D effort targeted to new robotic and drone applications Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™,
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release
First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom